GL CHEMTEC, a North American-based CDMO providing advanced chemistry services to the pharma and biopharma sectors, has completed its state-of-the-art Good Manufacturing Practice (GMP) Kilo lab facility.  

The new, fully operational Kilo scale GMP facility will serve increased customer demand for advanced materials for use in human clinical trials. This investment enables GL CHEMTEC to bridge the gap between preclinical offerings and first-in-human, offering clients a pathway from concept to clinic and commercialization.

“Our new Kilo lab GMP facility represents a significant milestone in GL CHEMTEC’s growth strategy,” said Dr. Gamil Alhakimi, CEO. “By enhancing our capabilities in material science and drug delivery, we can better serve our customers with faster development cycles, superior quality control, and more efficient scaling processes.”

Key features of the new GMP facility:

                  •    Two state-of-the-art specialized rooms designed to meet ISO 8 particulate and microbiological specifications

                  •     Enhanced quality control systems

                  •     Significantly increased production capacity at the multi-Kilogram scale

                  •     A dedicated team of biomedical polymer science and drug delivery experts